CSIMarket
 


Humanigen Inc  (HGEN)
Other Ticker:  
 
 

HGEN's Net Income Growth by Quarter and Year

Humanigen Inc's Net Income results by quarter and year




HGEN Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -33.54 -32.30 -2.03
III Quarter September - -66.74 -30.75 -2.39
II Quarter June - -70.80 -24.02 -3.34
I Quarter March -21.28 -65.57 -2.47 -2.54
FY   -21.28 -236.65 -89.54 -10.30



HGEN Net Income first quarter 2022 Y/Y Growth Comment
Humanigen Inc in the first quarter 2022 recorded net loss of $ -21.28 millions.

According to the results reported in the first quarter 2022, Humanigen Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Humanigen Inc' s Net Income no change of % ranks overall at the positon no. in the first quarter 2022.




HGEN Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Humanigen Inc's first quarter 2022 Net Income $ -21.28 millions HGEN's Income Statement
Humanigen Inc's first quarter 2021 Net Income $ -65.57 millions Quarterly HGEN's Income Statement
New: More HGEN's historic Net Income Growth >>


HGEN Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Humanigen Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HGEN's I. Quarter Q/Q Net Income Comment
Even if Humanigen Inc in the I. Quarter 2022 revealed net loss of $ -21.28 millions, management said, that current results are recovery compare to the -33.54 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Humanigen Inc achieved highest sequential Net Income growth. While Humanigen Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HGEN's I. Quarter Q/Q Net Income Comment
Despite the fact, that Humanigen Inc in the I. Quarter 2022 revealed net loss of $ -21.28 millions, some analyst point out, that this are recovery in contrast to the -33.54 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Humanigen Inc achieved highest sequential Net Income growth. While Humanigen Inc's Net Income growth quarter on quarter, overall rank is .


Humanigen Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Income 12 Months Ending $ -192.36 $ -236.65 $ -235.40 $ -199.42 $ -152.64
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Humanigen Inc' has realized cumulative trailing twelve months net loss of $ -192 millions in the Mar 31 2022 period.

Humanigen Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Humanigen Inc' has realized cumulative trailing twelve months net loss of $ -192 millions in the Mar 31 2022 period.

Humanigen Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
HGEN's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for HGEN's Competitors
Net Income Growth for Humanigen Inc's Suppliers
Net Income Growth for HGEN's Customers

You may also want to know
HGEN's Annual Growth Rates HGEN's Profitability Ratios HGEN's Asset Turnover Ratio HGEN's Dividend Growth
HGEN's Roe HGEN's Valuation Ratios HGEN's Financial Strength Ratios HGEN's Dividend Payout Ratio
HGEN's Roa HGEN's Inventory Turnover Ratio HGEN's Growth Rates HGEN's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2022
Chemed Corporation-1.88%$ -1.882 millions
Biomx Inc -2.77%$ -2.773 millions
Ironwood Pharmaceuticals inc -2.82%$ -2.818 millions
Corcept Therapeutics Inc-2.85%$ -2.847 millions
Msa Safety Incorporated-2.89%$ -2.891 millions
Merit Medical Systems Inc-3.77%$ -3.769 millions
Addus Homecare Corporation-4.77%$ -4.767 millions
Idexx Laboratories Inc-5.05%$ -5.054 millions
Hca Healthcare Inc -7.28%$ -7.278 millions
National Research Corporation-7.51%$ -7.506 millions
Amgen Inc -10.33%$ -10.328 millions
Regeneron Pharmaceuticals Inc -12.71%$ -12.706 millions
Organon and Co -12.78%$ -12.782 millions
Blueriver Acquisition Corp -14.64%$ -14.638 millions
Intuitive Surgical Inc -15.12%$ -15.119 millions
Globus Medical Inc -15.98%$ -15.983 millions
Encompass Health Corporation-17.09%$ -17.093 millions
Molecular Templates inc -19.30%$ -19.296 millions
Royalty Pharma Plc-19.43%$ -19.434 millions
3m Company-19.91%$ -19.914 millions
Natus Medical Inc-20.58%$ -20.576 millions
Fulgent Genetics Inc -23.49%$ -23.486 millions
Quest Diagnostics Inc-23.88%$ -23.878 millions
Fonar Corporation-24.12%$ -24.122 millions
Hologic Inc-26.49%$ -26.488 millions
Integra Lifesciences Holdings Corp-27.52%$ -27.521 millions
Universal Health Services Inc -27.77%$ -27.765 millions
National Healthcare Corp-27.97%$ -27.966 millions
Incyte Corporation-29.03%$ -29.033 millions
Davita Inc -29.44%$ -29.439 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com